Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Gabriella Fontanini

1-50 of 200 results

View this query on the Wikidata Query Service
Relation of neovascularisation to metastasis of non-small-cell lung cancer

scientific article published in The Lancet
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer.

scientific article published on 14 July 2009
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.

scientific article
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients

scientific article published on 28 October 2014
ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases.

scientific article
Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial

scientific article published on 9 August 2010
Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.

scientific article
Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective Study

scientific article published on 01 June 1997
Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer

scientific article
Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma

scientific article published in June 1997
Microvessel count predicts metastatic disease and survival in non-small cell lung cancer

scientific article published on 01 September 1995
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase.

scientific article published on April 2003
FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer

scientific article published on 15 October 2013
Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2.

scientific article published in September 1994
Antitumor Activity of Combined Blockade of Epidermal Growth Factor Receptor and Protein Kinase A

scientific article published on 01 December 1996
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa).

scientific article published in October 2002
A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma.

scientific article published on February 2002
BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis

scientific article published on 7 July 2015
N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression

scientific article
Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype

article
Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer.

scientific article
Mutational analysis in cytological specimens of advanced lung adenocarcinoma: a sensitive method for molecular diagnosis.

scientific article published on December 2007
Small cell lung carcinoma (SCLC): the angiogenic phenomenon

scientific article published in June 2002
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors

scientific article published on 29 June 2014
Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.

scientific article published in January 1998
Osteopontin Expression and Prognostic Significance in Non-Small Cell Lung Cancer

scientific article published on 01 September 2005
Advanced stage thymomas and thymic carcinomas: results of multimodality treatments

scientific article published in June 2005
FOLFOXIRI in combination with panitumumab as first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic colorectal cancer patients: a phase II trial by the Gruppo Oncologico Nord Ovest (GONO).

scientific article published on 10 May 2013
Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression

scientific article
BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection.

scientific article
bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma

scientific article published on 01 April 1998
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin

scientific article published on 2 April 2013
Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas

scientific article published on January 1999
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.

scientific article published on April 2003
WWOX Expression in Different Histologic Types and Subtypes of Non-Small Cell Lung Cancer

scientific article published on 01 February 2007
Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression.

scientific article published on January 1997
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance

scientific article
Angiogenesis: An indicator of metastasis in non-small cell lung cancer invading the thoracic inlet

scientific article published on 01 June 1994
Let-7g and miR-21 expression in non-small cell lung cancer: Correlation with clinicopathological and molecular features

scientific article published on 02 July 2013
N-acetylcysteine inhibits endothelial cell invasion and angiogenesis

scientific article published on September 1999
Distal embolization during primary angioplasty: histopathologic features and predictability

scientific article published in July 2005
Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study.

scientific article published in April 2004
Telomerase activity and hTERT mRNA expression in glial tumors.

scientific article
Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer.

scientific article published on August 2005
MicroRNA signature in metastatic colorectal cancer patients treated with anti-EGFR monoclonal antibodies

scientific article
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer.

scientific article published on 8 December 2010
ALK rearrangement in a large series of consecutive non-small cell lung cancers: comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment.

scientific article published on 2 June 2014
Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma

scientific article
Mechanical Prevention of Distal Embolization During Primary Angioplasty

TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts

scholarly article

Paulina is supported by:

About Paulina

Help